Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Critical Reviews in Oncology/Hematology|May 3, 2026
Overcoming Conditional Immune Resistance in MSS and pMMR Colorectal Cancer: A Sequential Gating Framework for ImmunotherapyHusni Farah, Djamila Polatova, Jasur Rizaev, et al.
Molecular Neurobiology|November 26, 2025
miR-132 and Its Exosomal Form in Alzheimer's Disease: Linking Epigenetic Regulation to NeurodegenerationGhaleb Oriquat, Waleed K Abdulsahib, S Renuka Jyothi, et al.
Discover Nano|May 25, 2026
Evaluating the mechanisms and therapeutic potential of ZnO nanoparticles as selective anticancer agents for lung malignanciesHamdi Nsairat, Waleed K Abdulsahib, S Renuka Jyothi, et al.
Folia Microbiologica|September 28, 2025
β-Glucan in antiviral defense: mechanisms, immune modulation, and therapeutic prospectsAli M Atoom, Waleed K Abdulsahib, S Renuka Jyothi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 13, 2026
Multi-omic biomarkers in cardiovascular disease: Discovery to clinical translationTareq Nayef AlRamadneh, Waleed K Abdulsahib, Tushar B Gajjar, et al.
Clinical and Experimental Medicine|January 6, 2026
Non-Coding RNAs as key regulators of interferon signaling in cancer immunotherapy: mechanistic insights and clinical prospectsUsamah Sayed, Waleed K Abdulsahib, S Renuka Jyothi, et al.
Cancer Treatment and Research Communications|March 4, 2026
Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospectsUsamah Sayed, Waleed K Abdulsahib, S Renuka Jyothi, et al.
Critical Reviews in Oncology/Hematology|December 15, 2025
Phage therapy in cancer treatment: Mechanisms, emerging innovations, and translational progressChou-Yi Hsu, Djamila Polatova, Rania Hameed Hamad, et al.
Biotechnology Journal|May 28, 2026
Nanoparticle-Based Radiosensitization in Breast Cancer: A Multimodal Approach to Therapy and Immune RegulationSaleh A S AlAbdulhadi, Ali A Majeed, Djamila Polatova, et al.
Bioimpacts : BI|June 12, 2026
Integrin-linked kinase (ILK) in hematologic malignancies: Bridging molecular mechanisms to therapeutic innovationOmer Qutaiba B Allela, Abdulkareem Shareef, Ashishkumar Kyada, et al.
Pageof 2